Galen Robertson
Co-founder & CEO
Intravascular oxygenation · In developmentA new way
A new way
to give lungs
a rest.
Developing a catheter that delivers supplemental oxygen directly into the bloodstream.
Explore the technologyBuilt around an unmet clinical needResearch Triangle, North Carolina
Support the blood.
Rethink the pathway.
VQ is exploring an alternative approach to respiratory support: gas exchange inside the body, independent of the injured lungs. The work is driven by a question from critical care: what could a less invasive approach make possible?
The technologyInside the body.
Inside the body.
Outside convention.
A catheter-based approach designed to exchange gases directly with blood, without an external blood circuit.
Understand the approachA small device.
A fundamentally
different idea.
For the people behind progressYour perspective.
Your perspective.
Our next conversation.
Begin with the bedside.
Explore the clinical problem that inspired the technology, and discuss research questions with the team. This device remains in development.
Discuss clinical researchExplore the mechanism.
Discover the catheter concept and the interdisciplinary team developing it.
Explore the scienceMove the work forward.
Connect with the company about development, collaboration and partnership opportunities.
Start a partnership conversationFrom bedside
to possibility.
Meet the full team
Tobias Straube, MD
Co-founder & Chief Medical Officer
Pat Sterlina, MBA
VP of Research & Development
Stewart Farling, PhD
Co-founder & Lead Engineer
Work worth
following.
All company newsAt ELSO, a new oxygenation approach
Dr. Tobias Straube presented the technology and physiology behind VQ’s catheter at the 36th Annual ELSO Conference.
MedTech Innovator: recognition for the work ahead
VQ joined the 2025 cohort and was named a finalist for the Value and Execution awards.
A milestone for device development
The company announced $5 million in total capital, including a $1.65 million seed round and non-dilutive support.